Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays

Osamu Takamiya, S. Ishikawa, O. Ohnuma, H. Suehisa, K. Iijima, Y. Kayamori, S. Bando, K. Higashi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The clinical phenotype manifest by patients with factor VII (FVII) deficiency correlates poorly with that predicted by laboratory tests. Despite its importance, there are no data on the variability of inter-laboratory determinations of low to very low plasma FVII activity (FVII:C). Methods: We distributed three FVII-deficient plasma samples, prepared by immunoaffinity chromatography, to 58 laboratories in Japan. All samples were assayed using standardized reference plasma as a calibrator. Recombinant thromboplastin was also supplied as a common reagent. Results: In the case of sample A, which had a very low FVII:C, the use of standardized reference plasma and thromboplastin, lowered the variability of inter-laboratory measurements, when compared with the variability observed when samples were assayed using the respective laboratory's routine method. Conclusions: The data obtained indicated that results for samples with a very low FVII:C were greatly influenced by the number of plasma dilutions used in constructing a standard activity curve, and also by the type of calibrator and thromboplastin. Such variability was not seen for samples with moderate FVII:C. We conclude that it is necessary to develop a more sensitive and accurate FVII:C measurement system for the diagnosis and treatment of FVII deficiency.

Original languageEnglish
Pages (from-to)1686-1692
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume5
Issue number8
DOIs
Publication statusPublished - Aug 1 2007

Fingerprint

Factor VII
Thromboplastin
Factor VII Deficiency
Chromatography
Japan
Phenotype

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Takamiya, O., Ishikawa, S., Ohnuma, O., Suehisa, H., Iijima, K., Kayamori, Y., ... Higashi, K. (2007). Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays. Journal of Thrombosis and Haemostasis, 5(8), 1686-1692. https://doi.org/10.1111/j.1538-7836.2007.02612.x

Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays. / Takamiya, Osamu; Ishikawa, S.; Ohnuma, O.; Suehisa, H.; Iijima, K.; Kayamori, Y.; Bando, S.; Higashi, K.

In: Journal of Thrombosis and Haemostasis, Vol. 5, No. 8, 01.08.2007, p. 1686-1692.

Research output: Contribution to journalArticle

Takamiya, O, Ishikawa, S, Ohnuma, O, Suehisa, H, Iijima, K, Kayamori, Y, Bando, S & Higashi, K 2007, 'Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays', Journal of Thrombosis and Haemostasis, vol. 5, no. 8, pp. 1686-1692. https://doi.org/10.1111/j.1538-7836.2007.02612.x
Takamiya, Osamu ; Ishikawa, S. ; Ohnuma, O. ; Suehisa, H. ; Iijima, K. ; Kayamori, Y. ; Bando, S. ; Higashi, K. / Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays. In: Journal of Thrombosis and Haemostasis. 2007 ; Vol. 5, No. 8. pp. 1686-1692.
@article{eb39129ed6d7475393c323bd434cd551,
title = "Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays",
abstract = "Background: The clinical phenotype manifest by patients with factor VII (FVII) deficiency correlates poorly with that predicted by laboratory tests. Despite its importance, there are no data on the variability of inter-laboratory determinations of low to very low plasma FVII activity (FVII:C). Methods: We distributed three FVII-deficient plasma samples, prepared by immunoaffinity chromatography, to 58 laboratories in Japan. All samples were assayed using standardized reference plasma as a calibrator. Recombinant thromboplastin was also supplied as a common reagent. Results: In the case of sample A, which had a very low FVII:C, the use of standardized reference plasma and thromboplastin, lowered the variability of inter-laboratory measurements, when compared with the variability observed when samples were assayed using the respective laboratory's routine method. Conclusions: The data obtained indicated that results for samples with a very low FVII:C were greatly influenced by the number of plasma dilutions used in constructing a standard activity curve, and also by the type of calibrator and thromboplastin. Such variability was not seen for samples with moderate FVII:C. We conclude that it is necessary to develop a more sensitive and accurate FVII:C measurement system for the diagnosis and treatment of FVII deficiency.",
author = "Osamu Takamiya and S. Ishikawa and O. Ohnuma and H. Suehisa and K. Iijima and Y. Kayamori and S. Bando and K. Higashi",
year = "2007",
month = "8",
day = "1",
doi = "10.1111/j.1538-7836.2007.02612.x",
language = "English",
volume = "5",
pages = "1686--1692",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays

AU - Takamiya, Osamu

AU - Ishikawa, S.

AU - Ohnuma, O.

AU - Suehisa, H.

AU - Iijima, K.

AU - Kayamori, Y.

AU - Bando, S.

AU - Higashi, K.

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Background: The clinical phenotype manifest by patients with factor VII (FVII) deficiency correlates poorly with that predicted by laboratory tests. Despite its importance, there are no data on the variability of inter-laboratory determinations of low to very low plasma FVII activity (FVII:C). Methods: We distributed three FVII-deficient plasma samples, prepared by immunoaffinity chromatography, to 58 laboratories in Japan. All samples were assayed using standardized reference plasma as a calibrator. Recombinant thromboplastin was also supplied as a common reagent. Results: In the case of sample A, which had a very low FVII:C, the use of standardized reference plasma and thromboplastin, lowered the variability of inter-laboratory measurements, when compared with the variability observed when samples were assayed using the respective laboratory's routine method. Conclusions: The data obtained indicated that results for samples with a very low FVII:C were greatly influenced by the number of plasma dilutions used in constructing a standard activity curve, and also by the type of calibrator and thromboplastin. Such variability was not seen for samples with moderate FVII:C. We conclude that it is necessary to develop a more sensitive and accurate FVII:C measurement system for the diagnosis and treatment of FVII deficiency.

AB - Background: The clinical phenotype manifest by patients with factor VII (FVII) deficiency correlates poorly with that predicted by laboratory tests. Despite its importance, there are no data on the variability of inter-laboratory determinations of low to very low plasma FVII activity (FVII:C). Methods: We distributed three FVII-deficient plasma samples, prepared by immunoaffinity chromatography, to 58 laboratories in Japan. All samples were assayed using standardized reference plasma as a calibrator. Recombinant thromboplastin was also supplied as a common reagent. Results: In the case of sample A, which had a very low FVII:C, the use of standardized reference plasma and thromboplastin, lowered the variability of inter-laboratory measurements, when compared with the variability observed when samples were assayed using the respective laboratory's routine method. Conclusions: The data obtained indicated that results for samples with a very low FVII:C were greatly influenced by the number of plasma dilutions used in constructing a standard activity curve, and also by the type of calibrator and thromboplastin. Such variability was not seen for samples with moderate FVII:C. We conclude that it is necessary to develop a more sensitive and accurate FVII:C measurement system for the diagnosis and treatment of FVII deficiency.

UR - http://www.scopus.com/inward/record.url?scp=34447635881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447635881&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2007.02612.x

DO - 10.1111/j.1538-7836.2007.02612.x

M3 - Article

C2 - 17488350

AN - SCOPUS:34447635881

VL - 5

SP - 1686

EP - 1692

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 8

ER -